Adverse Syndromes and Psychiatric Drugs: A Clinical GuidePeter Haddad, Serdar Dursun, Bill Deakin Pharmacotherapy is an important part of the treatment of most major psychiatric disorders. Although psychiatric drugs can have immense benefits for patients, adverse syndromes are common, causing significant distress for patients. Some side-effects are potentially life threatening if not detected and treated appropriately. Despite the importance of this subject there is a great shortage of practical advice on this topic. This book will help psychiatrists, GPs, pharmacists and nurses prevent, recognize, and manage adverse syndromes associated with psychiatric drugs. It provides an easily readable account of almost all the adverse syndromes that clinicians will ever encounter. Each section is written by an authority in the area, with each syndrome clearly laid out to include the following information: clinical features; pharmacological basis; differential diagnosis; management; risk factors and prevention. Summary tables are also provided, along with key references for further reading. Clearly written and authoritative, this book will be of enormous practical value to all clinicians managing patients who have been prescribed psychiatric drugs. |
Contents
1 Extrapyramidal syndromes | 1 |
2 Neuroleptic malignant syndrome | 21 |
3 Serotonin syndrome | 37 |
4 Torsade de pointes and sudden death | 51 |
5 Hyperprolactinaemia | 69 |
6 Adverse syndromes associated with lithium | 89 |
7 Sexual dysfunction | 125 |
8 Diabetes mellitus | 145 |
11 Antipsychotic discontinuation syndromes | 207 |
12 Blood dyscrasias | 221 |
13 Benzodiazepine dependence | 239 |
14 Syndrome of inappropriate antidiuretic hormone secretion | 261 |
15 Dermatological syndromes | 271 |
anticholinergic toxicity clozapine toxicity and hypertensive crisis with MAOIs | 293 |
309 | |
Plate Section | 317 |
Other editions - View all
Adverse Syndromes and Psychiatric Drugs: A clinical guide Peter Haddad,Serdar Dursun,Bill Deakin Limited preview - 2004 |
Adverse Syndromes and Psychiatric Drugs: A clinical guide Peter Haddad,Serdar Dursun,Bill Deakin No preview available - 2004 |
Common terms and phrases
abnormalities acute agents agranulocytosis akathisia anticholinergic antidepressant antipsychotic drugs arrhythmia Ashton associated atypical antipsychotics benzodiazepine withdrawal bipolar carbamazepine cardiac cent chlorpromazine chronic Clin Psychiatry Clin Psychopharmacol Clinical features clozapine conventional antipsychotics D2 receptors depression diabetes insipidus Differential diagnosis discontinuation symptoms discontinuation syndrome disorder dopamine dopaminergic dosage double-blind drug-induced Drugs causing syndrome dystonia effects of lithium extrapyramidal fluoxetine glucose Haddad haloperidol hormone hyperprolactinaemia hyponatraemia hypothyroidism impairment incidence increased risk induced inhibition insulin Lader lithium long-term Management MAOI medication monitoring muscle neuroleptic malignant syndrome occur olanzapine paroxetine patients Pharmacological basis Pharmacological mechanism plasma pregnancy prescribed prolactin prolactin levels prolongation Psychiatry psychotropic drugs QT interval reactions reduced renal reported Risk factors risperidone schizophrenia selective serotonin reuptake serotonergic serotonin reuptake inhibitors serotonin syndrome serotonin toxicity serum severe sexual dysfunction sexual function SIADH side effects SSRIs studies sudden death tardive dyskinesia therapy thioridazine thyroid torsade treated Tyrer valproate venlafaxine women